Skip to main content
Top
Published in: Inflammation Research 8/2009

01-08-2009 | Short Communication

Ozone oxidative preconditioning reduces nitrite levels in blood serum in LPS: induced endotoxic shock in mice

Authors: Ricardo González Alvarez, Zullyt Barbara Zamora, Aluet Borrego, René Delgado, Siegfried Schulz, Yaima Alonso

Published in: Inflammation Research | Issue 8/2009

Login to get access

Abstract

Objective and design

Reactive oxygen species, and also reactive species of nitrogen such as nitric oxide, play an important role in the pathogenesis of peritonitis and septic shock. Ozone oxidative preconditioning (OOP) has shown protective effects in various experimental models of peritonitis in rats and endotoxic shock in mice. Currently, strong evidence is available that this protective effect of OOP is due to its action on the balance between endogenous antioxidants and pro-oxidants, which is favorable for anti-oxidant defense. The aim of this research was to elucidate whether or not OOP is able to reduce nitrite levels in blood serum of mice treated with lipopolysaccharide (LPS). We used an experimental model of endotoxic shock induced by LPS in mice in which the animals were pre-treated with ozone/oxygen mixture for 5 days (once daily), with injection of LPS 24 h thereafter to induce endotoxic shock.

Results

Mice pretreated with OOP showed a significant decrease in nitrite levels with all three doses tested [0.2 mg/kg (50.91%), 0.4 mg/kg (47.3%) and 1.2 mg/kg (34.6%)].

Conclusions

Ozone oxidative preconditioning significantly reduced nitrite levels in blood serum of mice with endotoxic shock induced by LPS. We propose that OOP merits further testing in studies as a potential alternative treatment to reduce nitrite levels in patients with sepsis syndrome and septic shock.
Literature
1.
go back to reference Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425–35.PubMedCrossRef Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425–35.PubMedCrossRef
2.
go back to reference Schulz S, Rodriguez ZZ, Mutters R, Menéndez S, Bette M. Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats. Eur J Surgery Res. 2003;35:26–34.CrossRef Schulz S, Rodriguez ZZ, Mutters R, Menéndez S, Bette M. Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats. Eur J Surgery Res. 2003;35:26–34.CrossRef
3.
go back to reference Bette M, Nusring RM, Mutters R, Zamora Z, Menendez S, Schulz S. Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after pre-conditioning of rats with O3/O2-pneumoperitoneum. Shock. 2006;1:26–9. Bette M, Nusring RM, Mutters R, Zamora Z, Menendez S, Schulz S. Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after pre-conditioning of rats with O3/O2-pneumoperitoneum. Shock. 2006;1:26–9.
4.
go back to reference Zamora ZB, Borrego A, López OY, et al. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;1:16–22.CrossRef Zamora ZB, Borrego A, López OY, et al. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;1:16–22.CrossRef
5.
go back to reference Kengatharan KM, De Kimpe SJ, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram-positive shock. Br J Pharmacol. 1996;116:1411–21. Kengatharan KM, De Kimpe SJ, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram-positive shock. Br J Pharmacol. 1996;116:1411–21.
6.
go back to reference Grisham MB, Jourd Hevil D, Wink DA. Nitric oxide I physiological chemistry of nitric oxide and its metabolites, implications in inflammation. Am J Physiol. 1999;39:G315–21. Grisham MB, Jourd Hevil D, Wink DA. Nitric oxide I physiological chemistry of nitric oxide and its metabolites, implications in inflammation. Am J Physiol. 1999;39:G315–21.
8.
go back to reference Romay CH, Delgado R, Remirez D, Gonzalez R, Rojas A. Effects of phycocianin extract on tumor necrosis factor α and nitrite levels in serum of mice treated with endotóxina. Arzmein Forsch (Drug Res). 2001;51:733–6. Romay CH, Delgado R, Remirez D, Gonzalez R, Rojas A. Effects of phycocianin extract on tumor necrosis factor α and nitrite levels in serum of mice treated with endotóxina. Arzmein Forsch (Drug Res). 2001;51:733–6.
9.
go back to reference Zamora ZR, Borrego A, Lopez O, Delgado R, Monendez S, Schulz S. Inhibition of TNF-alpha release during endotoxic shock by ozone oxidative preconditioning in mice. ArzneimForsch Drug Res. 2004;54(12):906–9. Zamora ZR, Borrego A, Lopez O, Delgado R, Monendez S, Schulz S. Inhibition of TNF-alpha release during endotoxic shock by ozone oxidative preconditioning in mice. ArzneimForsch Drug Res. 2004;54(12):906–9.
10.
go back to reference Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA. In vivo induction of nitrite by tumor necrosis factor, lymphotoxin and interleukin 1: possible roles in malarial. Infect Immun. 1992;60:3725–30.PubMed Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA. In vivo induction of nitrite by tumor necrosis factor, lymphotoxin and interleukin 1: possible roles in malarial. Infect Immun. 1992;60:3725–30.PubMed
11.
go back to reference León OS, Menéndez S, Merino N, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Med Inflamm. 1999;7:289–94. León OS, Menéndez S, Merino N, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Med Inflamm. 1999;7:289–94.
12.
go back to reference Peralta C, Leon OS, Xaus C, Prats N, Jalil EC. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant–prooxidant balance. Free Rad Res. 1999;31:191–6.CrossRef Peralta C, Leon OS, Xaus C, Prats N, Jalil EC. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant–prooxidant balance. Free Rad Res. 1999;31:191–6.CrossRef
13.
go back to reference Madej P, Plewka A, Madej JA, et al. Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation. 2007;30:52–8.PubMedCrossRef Madej P, Plewka A, Madej JA, et al. Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation. 2007;30:52–8.PubMedCrossRef
14.
go back to reference Cuzzocrea S, Riley DP, Capute AP, Salvemin D. Antioxidant therapy; a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135–59.PubMed Cuzzocrea S, Riley DP, Capute AP, Salvemin D. Antioxidant therapy; a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135–59.PubMed
15.
go back to reference Fretland DJ, Widomski DL, Anglin CP. Specific inhibitors of inducible nitric oxide synthase: efficacy in a rodent model of sepsis. Inflamm Res. 1999;48(Suppl 2):S107–8.PubMedCrossRef Fretland DJ, Widomski DL, Anglin CP. Specific inhibitors of inducible nitric oxide synthase: efficacy in a rodent model of sepsis. Inflamm Res. 1999;48(Suppl 2):S107–8.PubMedCrossRef
Metadata
Title
Ozone oxidative preconditioning reduces nitrite levels in blood serum in LPS: induced endotoxic shock in mice
Authors
Ricardo González Alvarez
Zullyt Barbara Zamora
Aluet Borrego
René Delgado
Siegfried Schulz
Yaima Alonso
Publication date
01-08-2009
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 8/2009
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-009-0055-1

Other articles of this Issue 8/2009

Inflammation Research 8/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine